Leu-Pro-Phe-Phe-Asp blends hydrophobic, aromatic, and acidic residues that produce a balanced environment for folding studies. Proline imposes steric constraints that guide conformational sampling. The sequence serves as a substrate model for enzyme specificity research. Applications include structure-function analysis, binding studies, and synthetic method development.
CAT No: R2446
CAS No:182912-74-9
Synonyms/Alias:182912-74-9;Leu-Pro-Phe-Phe-Asp;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]butanedioic acid;(PRO18,ASP21)-AMYLOID BETA-PROTEIN (17-21);LPFFD;Beta-Sheet Breaker Peptide iA|A5;Beta-Sheet Breaker Peptide iA5;DTXSID00436123;HY-P1047;FP109385;PD163358;CS-0025317;(Pro18,Asp21)-Amyloid b-Protein (17-21) trifluoroacetate salt;L-Aspartic acid,L-leucyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-;(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-AMINO-4-METHYLPENTANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-PHENYLPROPANAMIDO]-3-PHENYLPROPANAMIDO]BUTANEDIOIC ACID;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.